CAR T-cell therapy involves several steps, starting with the collection of T cells from the patient through apheresis. The cells are then genetically engineered in a laboratory to produce CARs. After expansion and quality testing, the modified T cells are infused back into the patient. This process requires a highly specialized medical team, and the therapy is typically administered in a hospital setting where patients can be monitored for any adverse reactions.
